Showing 341 - 360 results of 580 for search '"Influenza', query time: 0.07s Refine Results
  1. 341
  2. 342
  3. 343

    Single Dose of Attenuated Vaccinia Viruses Expressing H5 Hemagglutinin Affords Rapid and Long-Term Protection Against Lethal Infection with Highly Pathogenic Avian Influenza A H5N1 Virus in Mice and Monkeys by Fumihiko Yasui, Keisuke Munekata, Tomoko Fujiyuki, Takeshi Kuraishi, Kenzaburo Yamaji, Tomoko Honda, Sumiko Gomi, Misako Yoneda, Takahiro Sanada, Koji Ishii, Yoshihiro Sakoda, Hiroshi Kida, Shosaku Hattori, Chieko Kai, Michinori Kohara

    Published 2025-01-01
    “…Background/Objectives: In preparation for a potential pandemic caused by the H5N1 highly pathogenic avian influenza (HPAI) virus, pre-pandemic vaccines against several viral clades have been developed and stocked worldwide. …”
    Get full text
    Article
  4. 344

    Estimating the reproduction number from the initial phase of the Spanish flu pandemic waves in Geneva, Switzerland by Gerardo Chowell, Catherine E. Ammon, Nicolas W. Hengartner, James M. Hyman

    Published 2007-04-01
    Subjects: “…spanish flu; 1918 influenza pandemic; reproduction number;boot- strapping; nonlinear curve fitting; uncertaintyquantification; geneva; switzerland.…”
    Get full text
    Article
  5. 345
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350

    Viral Etiology of Chronic Obstructive Pulmonary Disease Exacerbations during the A/H1N1pdm09 Pandemic and Postpandemic Period by Ivan Sanz, Sonia Tamames, Silvia Rojo, Mar Justel, José Eugenio Lozano, Carlos Disdier, Tomás Vega, Raúl Ortiz de Lejarazu

    Published 2015-01-01
    “…Emergence of A/H1N1pdm influenza virus in the 2009 pandemic changed the viral etiology of exacerbations that were reported before the pandemic. …”
    Get full text
    Article
  11. 351

    Ode to Oseltamivir and Amantadine? by JM Conly, BL Johnston

    Published 2006-01-01
    “…Influenza A and B viruses are the two major types of influenza viruses that cause human epidemic disease. …”
    Get full text
    Article
  12. 352
  13. 353

    Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients by Joji Nagasaki, Masahiro Manabe, Kentaro Ido, Hiroyoshi Ichihara, Yasutaka Aoyama, Tadanobu Ohta, Yoshio Furukawa, Atsuko Mugitani

    Published 2016-01-01
    “…We report the cases of three elderly patients who developed ITP after receiving influenza vaccinations. The platelet count of an 81-year-old woman fell to 27,000/μL after she received an influenza vaccination. …”
    Get full text
    Article
  14. 354
  15. 355

    Prevalence and Genetic Characteristics of Human Bocaviruses Detected in Patients with Acute Respiratory Infections in Bulgaria by Neli Korsun, Svetla Angelova, Ivelina Trifonova, Silvia Voleva, Iliana Grigorova, Iren Tzotcheva, Sirma Mileva, Penka Perenovska

    Published 2021-01-01
    “…HBoV was identified in 98 (5.3%) patients and was the 6th most prevalent virus after respiratory-syncytial virus (20.4%), influenza A(H1N1)pdm09 (11.1%), A(H3N2) (10.5%), rhinoviruses (9.9%), and adenoviruses (6.8%). …”
    Get full text
    Article
  16. 356

    Fatal H1N1-Related Acute Necrotizing Encephalopathy in an Adult by Yu-Jin Lee, D. Scott Smith, Vivek A. Rao, Robert D. Siegel, Jon Kosek, Carol A. Glaser, Alexander C. Flint

    Published 2011-01-01
    “…Acute necrotizing encephalopathy (ANE) is a severe neurological complication of influenza infection, including H1N1 influenza. Many cases of ANE have been reported in the pediatric literature, but very few cases have been described in adults. …”
    Get full text
    Article
  17. 357
  18. 358

    Planning for the Pandemic by Joanne Embree

    Published 2006-01-01
    “…Will it have the same transmission characteristics as the yearly endemic influenza strains or will it be so different that our routine infection prevention precautions for influenza will be ineffective? …”
    Get full text
    Article
  19. 359

    Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study by Molly Moore Jeffery, Lucas Oliveira J e Silva, Fernanda Bellolio, Nathan W Cummins, Timothy M Dempsey, Vesna D Garovic, Andrew Limper

    Published 2022-07-01
    “…Objectives Evaluate the associations between patients taking ACE inhibitors and angiotensin receptor blockers (ARBs) and their clinical outcomes after an acute viral respiratory illness (AVRI) due to COVID-19.Design Retrospective cohort.Setting The USA; 2017–2018 influenza season, 2018–2019 influenza season, and 2019–2020 influenza/COVID-19 season.Participants People with hypertension (HTN) taking an ACEi, ARB or other HTN medications, and experiencing AVRI.Main outcome measures Change in hospital admission, intensive care unit (ICU) or coronary care unit (CCU), acute respiratory distress (ARD), ARD syndrome (ARDS) and all-cause mortality, comparing COVID-19 to pre-COVID-19 influenza seasons.Results The cohort included 1 059 474 episodes of AVRI (653 797 filled an ACEi or ARB, and 405 677 other HTN medications). 58.6% were women and 72.9% with age ≥65. …”
    Get full text
    Article
  20. 360